KCNJ5体质突变与单边原发性阿尔多斯特罗尼斯症患者的更好的长期结果有关
Chieh-Kai Chan1,2,3, Wei-Shiung Yang2,3, Yen-Hung Lin2,4,5
1Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu branch, Hsin-Chu City, Taiwan.
The Journal of clinical endocrinology and metabolism
|January 9, 2025
概括
经过手术的单边原发性阿尔多斯特隆症患者 (uPA) 携带KCNJ5突变,经过上腺切除术后心血管长期风险降低. 然而,低和更短的高血压持续时间等因素可能会减少这些益处.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
背景情况:
- 在经过手术的单边原发性阿尔多斯特隆症 (uPA) 患者中,KCNJ5体质突变的预后意义仍然不完全理解.
- 了解这些关联对于预测上腺切除术后患者的长期结果至关重要.
研究的目的:
- 研究KCNJ5体质突变与临床特征之间的关系.
- 评估KCNJ5突变对长期心血管事件和uPA患者在腎上腺切除术后死亡率的影响.
- 确定KCNJ5突变的预测因子及其对术后结果的影响.
主要方法:
- 一项对uPA患者进行纵向研究,这些患者在2013年至2017年期间接受了上腺切除术,随访时间为2020年.
- 分析1年后的完整临床成功,主要心脏和脑血管不良事件 (MACCEs) 和全因死亡率.
- 统计分析包括几率比率 (OR) 和危险比率 (HR) 来评估突变关联.
主要成果:
- 在358名研究患者中,KCNJ5体质突变在52.5%的患者中被发现.
- 年轻的年龄,较低的BMI,较低的和较大的瘤大小预测了KCNJ5突变.
- 患有KCNJ5突变的患者在1年内临床成功率更高,长期MACCE和死亡风险更低.
结论:
- 经过UPA手术的KCNJ5体质突变患者经历了长期MACCE和上腺切除术后死亡率降低的风险.
- 这些改善的结果受到包括基线水平,高血压持续时间,肥胖,eGFR和残留高血压在内的因素的调节.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
445
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
445
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K


